It is crucial that labs can rely on their slides for a seamless – and accurate – diagnosis. With many more commercial instruments focusing on flexibility and choice, these qualities are difficult to separate from subjectivity and complexity.
Data on a test that can detect HIV, hepatitis B and hepatitis C from a single drop of blood is being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases.
An international coalition of biomedical researchers has determined a new way to measure the growth rate of precancerous clones of blood stem cells that one day could help doctors lower their patients' risk of blood cancer.
New research has found molecular signature differences in the blood of patients who fully recover from Covid-19 and those who develop long Covid.
Multiple sclerosis affects three women for every one man. French scientists are studying the role of the sex hormones in order to better understand this discrepancy.
US scientists report using a single-atom-thick nanomaterial to simultaneously detect Covid-19 and flu viruses — at much lower levels and much more quickly than conventional tests for either.
A recent survey of more than 8,000 patients found that users overwhelmingly supported receiving their test results immediately, even if their provider had not yet reviewed them.
A team of scientists has successfully generated genetically defined mouse models for two subtypes of multiple myeloma. This will contribute to a better understanding of how the disease develops in humans.
For pancreatic cancer, the effect of immunotherapy is limited and differs between men and women. Researchers at Karolinska Institutet have now found a possible explanation for this sex difference.
Are you looking for a new software solution for your laboratory? Laboratory information systems by Clinisys offer future-proof solutions you can rely on!
Testing for genetic mutations in urine can detect bladder cancer years before the disease shows clinical symptoms, new research has shown - reaching more than a decade for the most common cancer type.
Hamamatsu Photonics announces the release of a new high-speed kinetic plate imager, the FDSS-GX, designed for kinetic cell-based assay development.
French scientists are developing and testing a new vaccine to combat allergic asthma. Their latest study results pave the way for the organization of a clinical trial.
Worldwide, about one million people are suffering from hepatocellular carcinoma (HCC). In Germany alone, there are 9,000 new patients each year, most of them men between 50 and 60 years. When liver cancer is detected early, the prognosis is excellent, says Professor Dr. Ali Canbay, Director of the Medical Clinic at the University Hospital/Knappschaftskrankenhaus Bochum. While, unfortunately,…
A second-generation lab test for early detection of cervical cancer is the most recent addition to Oncgnostics’ portfolio. In particular, the company’s solution will help women in countries with limited cancer screening. Moreover, new research on the early detection of vulval and vaginal cancer might soon enable the development of tests for these cancers.
A new mathematical model developed by Hokkaido University engineers uses wastewater samples to effectively forecast the number of clinical Covid-19 cases in a community five days in advance.
Researchers in Frankfurt have now been able to show how ferroptosis can be used to make immunotherapies against liver cancer more effective in mice.
A model organism used in laboratories for the past 100 years has evolved so extensively that it may no longer be fit for purpose, according to a new study on bacterial strain Escherichia coli K-12.
Researchers have developed a new blood test to detect prostate cancer which displays greater accuracy than the current prostate-specific antigen (PSA) method.
Researchers have developed a Raman microscope that can acquire information hundreds of times faster than the conventional method. This could help expand its usefulness in biomedical applications.
Researchers at the University of East Anglia are launching a project to make laboratories more accessible for people with disabilities.
Carriers of a specific bacteria have a 14% chance of developing an antibiotic resistant infection with 30 days of hospitalisation, according to new research from Amsterdam.
Canadian researchers are developing a new, ultra-sensitive biosensor to screen for Alzheimer’s disease and other diseases. The device has successfully completed the proof-of-concept stage.
The Netherlands Cancer Institute (NKI) will deploy a diagnostic platform from digital and computational pathology solutions provider Proscia, the company announced.
A new blood test that can track and follow the neurodegeneration in Alzheimer's disease - and exclude other dementias.